Is it possible to determine the type of kidney tumor from MRI scans? Soon to be PhD Justine van der Beek investigated this question. She also looked at how this could help to provide the child after the MRI scan with the most appropriate treatment. research.prinsesmaximacentrum.nl/en/news-events…

Organoid modelling of #CNSdevelopment in health #neurodevelopmentaldisorders .
ISDN Speakers: Benedetta Artegiani PrinsesMáximaCentrum, Alexandre Baffet Alexandre Baffet Institut Curie, Fikri Birey Emory University, Silvia Velasco Murdoch Children's Research Institute (MCRI). Submit abstracts bit.ly/ISDN2024

Today is Clinical Trials Day. 127 WMO clinical trials have started at the Máxima since its opening. 'The 120 employees of the TDC design and coordinate the often international studies and analyze the collected data' bit.ly/clinicaltrials…

🧬 Exploring oncolytic viruses as a potential treatment for children's brain tumors. Early research at Princess Máxima Center with Erasmus MC shows promise for targeting tumors with specific genetic profiles. More studies needed. Learn more: research.prinsesmaximacentrum.nl/en/news-events…

Pediatric oncology specialists gather this week at the annual SIOPE 🎗️ congress. Knowledge shared from the Máxima includes: nursing research, nausea, organoids, prevention of hearing loss, exercise care and quality of life. research.prinsesmaximacentrum.nl/en/news-events…

Our researchers are exploring a new type of immunotherapy with so-called 'MR1 T-cells'. They might be able to treat specific childhood cancers, such as leukemia and aggressive brain tumors. Read more: bit.ly/44r8TIJ

Scientists in the Dream3D Lab expanded their cutting-edge cell imaging tool to visualize how CAR-T and other immunotherapies work in liquid tumors – such as the blood cancer, leukemia – in real time. Their methods published in Nature Protocols. Read more:
research.prinsesmaximacentrum.nl/en/news-events…

Elilah Hendriks has received a KWFKankerbestrijding Young Investigator Grant. This enables her to study how fatty liver disease can lead to liver cancer in (young) adults and to look at the role of metabolic changes in mutated liver cells. research.prinsesmaximacentrum.nl/en/news-events… Hubrecht Institute Delilah Hendriks

Good news! The five-year survival of children with acute myeloid leukemia (AML) has continued to increase to 80%. In the 1990s it was 40%. To reach 100%, new clinical studies have been initiated. Over 60 hospitals from 16 countries are involved. research.prinsesmaximacentrum.nl/en/news-events…

We're proud to welcome prof. dr. Rene Medema as our new Chief Scientific Officer this week 🧡 He brings more than 10 years of executive experience Antoni van Leeuwenhoek and The Netherlands Cancer Institute. In addition to his role as CSO, he will keep leading his research group. Read more: prinsesmaximacentrum.nl/en/news-events…

The Princess Máxima Center will make DNA and clinical data from children with cancer widely available via the cloud to researchers working on childhood cancer, in the Netherlands and abroad:
research.prinsesmaximacentrum.nl/en/news-events…

Today, prof. Leontien Kremer spoke in Brussels at the #RiDaysEU  about the preliminary impact of PanCareFollowUp and the need for research and care for pediatric cancer survivors in Europe. Through int. research we aim to improve the quality of life for survivors worldwide.

Lieve Tytgat has been appointed professor of Biomarkers in pediatric solid tumors at UMC Utrecht. As clinical scientist, she focuses on liquid biopsies in childhood cancer. Congratulations, prof. Tytgat! 🎉🧡 Read more: research.prinsesmaximacentrum.nl/en/news-events… Cancer Research UMC Utrecht UMC Utrecht Child Health

Scientists have found a better way to give an important leukemia drug, PEGasparaginase. Leiah Brigitha: ‘This new approach allows more children to complete the full course of treatment, which contributes to a better chance of survival.’ Read more: research.prinsesmaximacentrum.nl/en/news-events…

🔎 Research news! 'This new study offers possibilities for possible future research into links between specific substances and the emergence of recognisable genetic signatures.' van Boxtel lab Hans Clevers Hubrecht Institute Oncode Institute Read ➡ research.prinsesmaximacentrum.nl/en/news-events…

📢 Announcing five new global #CancerGrandChallenges teams! 📢

We're thrilled to announce five new teams, each receiving up to $25m over five years to tackle some of cancer's toughest challenges.

Meet the teams: bit.ly/3Oqe58O

Cancer Research UK National Cancer Institute

Dr. Ruben van Boxtel van Boxtel lab has been awarded a prestigious NWO Nieuws Vici grant to further expand his research into the molecular underpinnings of late effects of childhood cancer treatment. Congrats, Ruben! 👏🧡 Read more: bit.ly/3Igi9oQ

The survival of children with an aggressive form of T cell leukemia has nearly doubled, from 28% to 55%. But we still have a way to go. That is why international project ATG4TAL was started. research.prinsesmaximacentrum.nl/en/news-events…

Four new research projects can start thanks to support from Stichting Kinderen Kankervrij 🧡 Scientists will develop immunotherapy for neuroblastoma, aim to unravel a soft tissue tumor to better understand its origin, and look at the role of microproteins in a bone tumor. research.prinsesmaximacentrum.nl/en/news-events…

How do stem cells behave in a new environment after transplantation? And is age locked into a stem cell or does it change in a younger environment? Specialists from the Máxima's single cell genomics facility and the Belderbos group try to find answers research.prinsesmaximacentrum.nl/en/news-events…